Effect of Sanqi Lixuezhigan recipe on non-alcoholic fatty liver in rats
Zou Yi-cha
Abstract
Zou Yi-cha
Abstract
Objective:To investigate the therapeutic efficacy of Sanqi Lixuezhigan recipe in the rat model of non-alcoholic fatty liver(NAFL),as well as the underlying mechanism.Methods:Thirty-six male Wistar rats were randomly divided into normal control group(C),model group(M) and Sanqi Lixuezhigan recipe group(Y).The rats of control group was fed with normal diet,M group and Y group with high-fat diet for 8 weeks,and from the fifth week rats of Y group were also administrated with Sanqi Lixuezhigan recipe once a day.Serum alanine aminotransferase(ALT),aspartate aminotransferase(AST),triglycerides(TG),total cholesterol(TC),LDL-C,HDL-C,FFA and FBG were measured.Liver histopathology was observed through hematoxylin-eosin staining(HE stain) and oil red O staining.Liver TG and TC were also determined.In addition,the protein expression of liver CYP2E1 and UCP2 was detected by Western blot.Results:Serum ALT and LDL-C in the model rat increased obviously,while impaired again in the rat of Sanqi Lixuezhigan recipe treatment group.In the liver of M group,diffusing hepatic steatosis was observed in liver lobules,and the liver TG and TC level increased dramatically.Compared with model,less area and extent of steatosis were found in the rat liver of Y group.And serum FFA content also decreased in Y group.Western blot showed up-regulated expression of CYP2E1 and down-regulated expression of UCP2 in the liver of M group,while their expression tended to the normal levels in the liver tissue of treatment group.Conclusion:Sanqi Lixuezhigan recipe can effectively improve non-alcoholic fatty liver in the high fat diet induced rat model.The lipid-lowering and blood-regulating function for this complex recipe may enable it to ameliorate liver lipid accumulation and liver injury through inhibiting oxidative stress and improve lipid metabolism.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the therapeutic efficacy of Sanqi Lixuezhigan recipe in the rat model of non-alcoholic fatty liver(NAFL),as well as the underlying mechanism.Methods:Thirty-six male Wistar rats were randomly divided into normal control group(C),model group(M) and Sanqi Lixuezhigan recipe group(Y).The rats of control group was fed with normal diet,M group and Y group with high-fat diet for 8 weeks,and from the fifth week rats of Y group were also administrated with Sanqi Lixuezhigan recipe once a day.Serum alanine aminotransferase(ALT),aspartate aminotransferase(AST),triglycerides(TG),total cholesterol(TC),LDL-C,HDL-C,FFA and FBG were measured.Liver histopathology was observed through hematoxylin-eosin staining(HE stain) and oil red O staining.Liver TG and TC were also determined.In addition,the protein expression of liver CYP2E1 and UCP2 was detected by Western blot.Results:Serum ALT and LDL-C in the model rat increased obviously,while impaired again in the rat of Sanqi Lixuezhigan recipe treatment group.In the liver of M group,diffusing hepatic steatosis was observed in liver lobules,and the liver TG and TC level increased dramatically.Compared with model,less area and extent of steatosis were found in the rat liver of Y group.And serum FFA content also decreased in Y group.Western blot showed up-regulated expression of CYP2E1 and down-regulated expression of UCP2 in the liver of M group,while their expression tended to the normal levels in the liver tissue of treatment group.Conclusion:Sanqi Lixuezhigan recipe can effectively improve non-alcoholic fatty liver in the high fat diet induced rat model.The lipid-lowering and blood-regulating function for this complex recipe may enable it to ameliorate liver lipid accumulation and liver injury through inhibiting oxidative stress and improve lipid metabolism.
Key concepts: Fatty liver, Steatosis, H&E stain, Internal medicine, Western blot, Oil Red O, Staining, Histopathology